Genetic alterations in 17β-hydroxysteroid dehydrogenase type 2 and 7 correlates with mRNA-expression but not estrogen levels in breast cancer

被引：0
|
作者：
Straume, Anne Hege [1 ]
Knappskog, Stian [1 ]
Lonning, Per Eystein [1 ]
机构：
[1] Univ Bergen, Bergen, Norway
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-355
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
355
引用
收藏
页数：1
相关论文
共 50 条
  • [21] 17β-hydroxysteroid dehydrogenase type 1 and 2 expression in the human fetus
    Takeyama, J
    Suzuki, T
    Hirasawa, G
    Muramatsu, Y
    Nagura, H
    Iinuma, K
    Nakamura, J
    Kimura, K
    Yoshihama, M
    Harada, N
    Andersson, S
    Sasano, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01): : 410 - 416
  • [22] Expression of 17β-hydroxysteroid dehydrogenase type 2 is associated with some clinicopathological features in gastric cancer
    Frycz, Bartosz Adam
    Murawa, Dawid
    Borejsza-Wysocki, Maciej
    Marciniak, Ryszard
    Murawa, Pawel
    Drews, Michal
    Jagodzinski, Pawel Piotr
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 70 : 24 - 27
  • [23] The 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Induced by the Androgen Signal in Endometrial Cancer.
    Hashimoto, Chiaki
    Miki, Yasuhiro
    Tanaka, Sota
    Takagi, Kiyoshi
    Fue, Misaki
    Doe, Zhulanqiqige
    Li, Bin
    Yaegashi, Nobuo
    Suzuki, Takashi
    Ito, Kiyoshi
    REPRODUCTIVE SCIENCES, 2017, 24 : 202A - 202A
  • [24] Intratumoral cortisol and 11ß-hydroxysteroid dehydrogenase 1 expression in estrogen receptornegative breast cancer
    Nishiwaki, Ryoki
    Miki, Yasuhiro
    Iwabuchi, Erina
    Yamazaki, Asumi
    Ebata, Akiko
    Ishida, Takanori
    Suzuki, Takashi
    CANCER SCIENCE, 2025, 116 : 544 - 544
  • [25] Ontogeny of 17 beta-hydroxysteroid dehydrogenase type 2 mRNA expression in the developing mouse placenta and fetus
    Mustonen, M
    Poutanen, M
    ChotteauLelievre, A
    deLaunoit, Y
    Isomaa, V
    Vainio, S
    Vihko, R
    Vihko, P
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1997, 134 (01) : 33 - 40
  • [26] Expression of 17β-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: A correlation to clinicopathological parameters
    Han, B.
    Li, S.
    Song, D.
    Poisson-Pare, D.
    Liu, G.
    Luu-The, V.
    Ouellet, J.
    Li, S.
    Labrie, F.
    Pelletier, G.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2008, 112 (4-5): : 194 - 200
  • [27] Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status
    Yuan-Ching Chang
    Chi-Kuan Chen
    Ming-Jen Chen
    Jiunn-Chang Lin
    Chi-Hsin Lin
    Wen-Chien Huang
    Shih-Ping Cheng
    Shan-Na Chen
    Chien-Liang Liu
    Annals of Surgical Oncology, 2017, 24 : 4033 - 4041
  • [28] Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status
    Chang, Yuan-Ching
    Chen, Chi-Kuan
    Chen, Ming-Jen
    Lin, Jiunn-Chang
    Lin, Chi-Hsin
    Huang, Wen-Chien
    Cheng, Shih-Ping
    Chen, Shan-Na
    Liu, Chien-Liang
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (13) : 4033 - 4041
  • [29] The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer
    Hilborn, Erik
    Stal, Olle
    Alexeyenko, Andrey
    Jansson, Agneta
    ONCOTARGET, 2017, 8 (37) : 62183 - 62194
  • [30] RELATIONSHIP BETWEEN ESTROGEN RECEPTORS, 17-BETA-HYDROXYSTEROID DEHYDROGENASE AND ESTROGEN CONTENT IN HUMAN-BREAST CANCER
    ABULHAJJ, YJ
    STEROIDS, 1979, 34 (02) : 217 - 225
12345